199 related articles for article (PubMed ID: 19584132)
1. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.
Epplein M; Nomura AM; Wilkens LR; Henderson BE; Kolonel LN
Am J Epidemiol; 2009 Aug; 170(4):507-14. PubMed ID: 19584132
[TBL] [Abstract][Full Text] [Related]
2. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH
Gastroenterology; 2012 Mar; 142(3):442-452.e5; quiz e22-3. PubMed ID: 22108196
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
4. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis.
Abnet CC; Freedman ND; Kamangar F; Leitzmann MF; Hollenbeck AR; Schatzkin A
Br J Cancer; 2009 Feb; 100(3):551-7. PubMed ID: 19156150
[TBL] [Abstract][Full Text] [Related]
6. Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study.
Kwon S; Ma W; Drew DA; Klempner SJ; Leonardo BM; Flynn JJ; Cao Y; Giovannucci EL; Bao Y; Fuchs CS; Song M; Chan AT
Cancer Prev Res (Phila); 2022 Apr; 15(4):265-272. PubMed ID: 34980677
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.
Ruder EH; Laiyemo AO; Graubard BI; Hollenbeck AR; Schatzkin A; Cross AJ
Am J Gastroenterol; 2011 Jul; 106(7):1340-50. PubMed ID: 21407185
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.
Daugherty SE; Pfeiffer RM; Sigurdson AJ; Hayes RB; Leitzmann M; Schatzkin A; Hollenbeck AR; Silverman DT
Am J Epidemiol; 2011 Apr; 173(7):721-30. PubMed ID: 21367875
[TBL] [Abstract][Full Text] [Related]
9. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden.
Akre K; Ekström AM; Signorello LB; Hansson LE; Nyrén O
Br J Cancer; 2001 Apr; 84(7):965-8. PubMed ID: 11286478
[TBL] [Abstract][Full Text] [Related]
10. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
12. Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality.
Bardia A; Ebbert JO; Vierkant RA; Limburg PJ; Anderson K; Wang AH; Olson JE; Vachon CM; Cerhan JR
J Natl Cancer Inst; 2007 Jun; 99(11):881-9. PubMed ID: 17551148
[TBL] [Abstract][Full Text] [Related]
13. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort.
Gill JK; Maskarinec G; Wilkens LR; Pike MC; Henderson BE; Kolonel LN
Am J Epidemiol; 2007 Nov; 166(10):1150-8. PubMed ID: 17698973
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
Mahipal A; Anderson KE; Limburg PJ; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study.
Gierach GL; Lacey JV; Schatzkin A; Leitzmann MF; Richesson D; Hollenbeck AR; Brinton LA
Breast Cancer Res; 2008; 10(2):R38. PubMed ID: 18447943
[TBL] [Abstract][Full Text] [Related]
18. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence.
Asgari MM; Maruti SS; White E
J Natl Cancer Inst; 2008 Jul; 100(13):967-71. PubMed ID: 18577752
[TBL] [Abstract][Full Text] [Related]
19. Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study.
Slatore CG; Au DH; Littman AJ; Satia JA; White E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1203-7. PubMed ID: 19293309
[TBL] [Abstract][Full Text] [Related]
20. Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study.
Shih C; Hotaling JM; Wright JL; White E
Urol Oncol; 2013 Nov; 31(8):1689-95. PubMed ID: 22795502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
